Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...
DALLAS - Lyft says it will bring autonomous robotaxis to Dallas as soon as 2026. Lyft says they have joined forces with ...
Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's ...
But have you ever considered how your oral hygiene affects your gut health? Enter the mouth-gut axis, which experts are now saying has a big impact on your overall wellbeing. Let us explain.
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...
Analyst Charlie Lederer of BMO Capital maintained a Hold rating on Axis Capital (AXS – Research Report), retaining the price target of $93.00. Charlie Lederer has given his Hold rating due to a ...
Reports Q4 revenue $1.47M vs $1.48M last year. Commenting on the 2024 financial results, Vince Tizzio, President and CEO of AXIS Capital (AXS), said: “2024 was an excellent year for AXIS.
Watch out because Woot's "Deals of the Day" feature $60 off for the Samsung Galaxy Buds 3 Pro and 53% off the sleek (and waterproof) B&O Beosound speaker. I have been a writer since 2006 when I ...
AST SpaceMobile can finally start testing its BlueBird satellites with AT&T phones in the US. The FCC today issued a special temporary authority to AST SpaceMobile, giving the company until May 30 ...
In an age where the quest for vitality and longevity has taken center stage, Nature’s Blast YouthSpark emerges as a beacon of hope for those looking to revitalize their bodies at a cellular level.
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries Johnson & Johnson has agreed to acquire neuroscience specialist Intra-Cellular Therapies for almost $15 billion ...